Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)

Michael J. Morris, Jose Mauricio Mota, Kristine Lacuna, Patrick Hilden, Martin Gleave, Michael A. Carducci, Fred Saad, Erica D. Cohn, Julie Filipenko, Glenn Heller, Neal Shore, Andrew J. Armstrong, Howard I. Scher

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)'. Together they form a unique fingerprint.

Medicine & Life Sciences